Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Heine, Markus ^a   Nollau, Peter ^a   Masslo, Christoph ^a   Nielsen, Peter ^a   Freund, Barbara ^a   Bruns, Oliver T ^b,c   Reimer, Rudolph ^b   Hohenberg, Heinrich ^b   Peldschus, Kersten ^a   Ittrich, Harald ^a   Schumacher, Udo ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE; LYMPHOCYTE ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY T84.1; UNCLASSIFIED DRUG; ALBUMINOID; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CD66 ANTIGENS; CELL ADHESION MOLECULE; EVANS BLUE; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOLECULAR IMAGING; MOUSE; NONHUMAN; PANCREAS CANCER; PROTEIN EXPRESSION; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL STRAIN CACO 2; CHEMISTRY; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MALE; METABOLISM; METASTASIS; METHODOLOGY; MOUSE MUTANT; TUMOR CELL LINE;

ALBUMINS; ANIMALS; ANTIGENS, CD; BIOLOGICAL MARKERS; CACO-2 CELLS; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; CELL LINE, TUMOR; EVANS BLUE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC VESSELS; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; MOLECULAR IMAGING; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RNA, MESSENGER;

EID: 82655180418     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028030     Document Type: Article

References (44)

1. Edlund M, Gaardsvoll H, Bock E, Obrink B, (1993) Different isoforms and stock-specific variants of the cell adhesion molecule C-CAM (cell-CAM 105) in rat liver. Eur J Biochem 213: 1109-1116.
2. Kuespert K, Pils S, Hauck CR, (2006) CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol 18: 565-571.
3. Singer BB, Scheffrahn I, Obrink B, (2000) The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. Cancer Res 60: 1236-1244.
4. Boulton IC, Gray-Owen SD, (2002) Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat Immunol 3: 229-236.
5. Schmitter T, Agerer F, Peterson L, Munzner P, Hauck CR, (2004) Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens. J Exp Med 199: 35-46.
6. Kirshner J, Chen CJ, Liu P, Huang J, Shively JE, (2003) CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc Natl Acad Sci U S A 100: 521-526.
7. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, et al. (2003) Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 21: 3638-3646.
8. Jaques G, Bepler G, Holle R, Wolf M, Hannich T, et al. (1988) Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer. Cancer 62: 125-134.
9. Thies A, Moll I, Berger J, Wagener C, Brummer J, et al. (2002) CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol 20: 2530-2536.
10. Laack E, Nikbakht H, Peters A, Kugler C, Jasiewicz Y, et al. (2002) Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. J Clin Oncol 20: 4279-4284.
11. Steward AM, Nixon D, Zamcheck N, Aisenberg A, (1974) Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer 33: 1246-1252.
12. O'Brien CA, Pollett A, Gallinger S, Dick JE, (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
13. Park JG, Frucht H, LaRocca RV, Bliss DP Jr, Kurita Y, et al. (1990) Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50: 2773-2780.
14. Planque C, Kulasingam V, Smith CR, Reckamp K, Goodglick L, et al. (2009) Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines. Mol Cell Proteomics 8: 2746-2758.
15. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, et al. (1978) Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299: 448-451.
16. Sharkey RM, Goldenberg DM, Goldenberg H, Lee RE, Ballance C, et al. (1990) Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. Cancer Res 50: 2823-2831.
17. Buraggi GL, Gasparini M, Seregni E, (1991) Immunoscintigraphy of colorectal carcinoma with an anti-CEA monoclonal antibody: a critical review. Int J Rad Appl Instrum B 18: 45-50.
18. Weissleder R, (2002) Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2: 11-18.
19. Lucka L, Fernando M, Grunow D, Kannicht C, Horst AK, et al. (2005) Identification of Lewis x structures of the cell adhesion molecule CEACAM1 from human granulocytes. Glycobiology 15: 87-100.
20. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, et al. (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818.
21. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW, (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23.
22. Schumacher U, Adam E, (1997) Lectin histochemical HPA-binding pattern of human breast and colon cancers is associated with metastases formation in severe combined immunodeficient mice. Histochem J 29: 677-684.
23. Carey TE, Takahashi T, Resnick LA, Oettgen HF, Old LJ, (1976) Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A 73: 3278-3282.
24. Fodstad O, Kjonniksen I, Aamdal S, Nesland JM, Boyd MR, et al. (1988) Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer Res 48: 4382-4388.
25. Kohler S, Ullrich S, Richter U, Schumacher U, (2010) E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. Br J Cancer 102: 602-609.
26. Lange A, Gustke H, Glassmeier G, Heine M, Zangemeister-Wittke U, et al. (2011) Neuronal differentiation by indomethacin and IBMX inhibits proliferation of small cell lung cancer cells in vitro. Lung Cancer 74: 178-187.
27. Kalinina T, Gungor C, Thieltges S, Moller-Krull M, Penas EM, et al. (2010) Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. BMC Cancer 10: 295.
28. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85.
29. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, et al. (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102: 1555-1577.
30. Marcus CD, Ladam-Marcus V, Cucu C, Bouche O, Lucas L, et al. (2009) Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol 72: 217-238.
31. Lehmann A, Janek K, Braun B, Kloetzel PM, Enenkel C, (2002) 20 S proteasomes are imported as precursor complexes into the nucleus of yeast. J Mol Biol 317: 401-413.
32. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM, (2001) Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107: 855-867.
33. Ergun S, Kilik N, Ziegeler G, Hansen A, Nollau P, et al. (2000) CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 5: 311-320.
34. Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, et al. (2005) Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11: 6116-6126.
35. Thies A, Mangold U, Moll I, Schumacher U, (2001) PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma. J Pathol 195: 537-542.
36. Tlsty TD, Coussens LM, (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150.
37. Kokkonen N, Ulibarri IF, Kauppila A, Luosujarvi H, Rivinoja A, et al. (2007) Hypoxia upregulates carcinoembryonic antigen expression in cancer cells. Int J Cancer 121: 2443-2450.
38. Schumacher U, Borisch B, Welsch U, (1990) Lectin binding in vivo versus lectin histochemistry. In: Lectins, Kocourek JFD, editors. St Louis Sigma Press.
39. Riethdorf L, Lisboa BW, Henkel U, Naumann M, Wagener C, et al. (1997) Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J Histochem Cytochem 45: 957-963.
40. Luo W, Tapolsky M, Earley K, Wood CG, Wilson DR, et al. (1999) Tumor-suppressive activity of CD66a in prostate cancer. Cancer Gene Ther 6: 313-321.
41. Carmeliet P, Jain RK, (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
42. Kreuzer F, (1982) Oxygen supply to tissues: the Krogh model and its assumptions. Experientia 38: 1415-1426.
43. Heldin CH, Rubin K, Pietras K, Ostman A, (2004) High interstitial fluid pressure- an obstacle in cancer therapy. Nat Rev Cancer 4: 806-813.
44. Jain RK, Baxter LT, (1988) Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res 48: 7022-7032.